CTP 354
Alternative Names: C-21191; CTP-354; D-L838417Latest Information Update: 10 Mar 2023
Price :
$50 *
At a glance
- Originator Concert Pharmaceuticals
- Class Analgesics; Antispastics; Fluorobenzenes; Organic deuterium compounds; Pyridazines; Small molecules; Triazoles
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Muscle spasticity; Neuropathic pain
Most Recent Events
- 06 Mar 2023 Concert Pharmaceuticals has been acquired by Sun Pharmaceutical Industries
- 28 Feb 2019 Cipla plans a clinical trial for Muscle spasticity
- 31 Jan 2019 CTP 354 licensed to Cipla worldwide